Autolus Therapeutics (AUTL) Other Operating Expenses (2017 - 2025)
Historic Other Operating Expenses for Autolus Therapeutics (AUTL) over the last 8 years, with Q1 2025 value amounting to -$3000.0.
- Autolus Therapeutics' Other Operating Expenses changed N/A to -$3000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was -$3000.0, marking a year-over-year increase of 9865.47%. This contributed to the annual value of -$223000.0 for FY2024, which is 9411.76% up from last year.
- According to the latest figures from Q1 2025, Autolus Therapeutics' Other Operating Expenses is -$3000.0.
- Autolus Therapeutics' 5-year Other Operating Expenses high stood at $3.8 million for Q1 2023, and its period low was -$515000.0 during Q4 2022.
- Over the past 5 years, Autolus Therapeutics' median Other Operating Expenses value was -$4000.0 (recorded in 2021), while the average stood at $433142.9.
- The largest annual percentage gain for Autolus Therapeutics' Other Operating Expenses in the last 5 years was 1277500.0% (2022), contrasted with its biggest fall of 1277500.0% (2022).
- Over the past 5 years, Autolus Therapeutics' Other Operating Expenses (Quarter) stood at -$4000.0 in 2021, then plummeted by 12775.0% to -$515000.0 in 2022, then soared by 95.53% to -$23000.0 in 2023, then plummeted by 869.57% to -$223000.0 in 2024, then skyrocketed by 98.65% to -$3000.0 in 2025.
- Its last three reported values are -$3000.0 in Q1 2025, -$223000.0 for Q3 2024, and -$23000.0 during Q2 2023.